|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 17730627.1 (espacenet) (Federated) (European Patent Register), 20170601 | | Patent/reg. no. and date | DK/EP 3463457, 20230628 | | Publication date | 20190410 | | Priority no. and date | US 201662344880 P, 20160602 | | EP pub. no. and date |
EP 3463457 20190410 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | PU278907DKQ | | Inventor | FARSACI, Benedetto, Rt. 206 & Province Line Road
Princeton
New Jersey 08543, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | PD-1-BLOKADE MED NIVOLUMAB VED REFRAKTÆRT HODGKINS LYMFOM | | Int. application no. | US2017035492 | | Int. publication no. | WO2017210453 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
